KRAS and cancer: To determine if miR181a1 and miR181b1 influence homeostasis of mutant-KRAS cancer cells, we used a CRISPR/Cas9-based knockout strategy using sgRNAs flanking the genomic region spanning the MiR181ab1 cluster (Supplemental Figure 5A).